Ambys Medicines
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $107M
Investors
- 7
About Ambys Medicines
Ambys Medicines, Inc.Founded in 2016 and based in South San Francisco, US, Ambys Medicines, Inc. specializes in liver cell therapy.Ambys Medicines focuses on liver cell therapy, aiming to develop treatments designed to address a range of liver diseases.Ambys Medicines has not publicly disclosed specific revenue figures. This investment will support the design and launch of new therapeutic products aimed at treating various liver conditions. The company is also exploring expansion opportunities into new markets to reach a broader patient population affected by liver diseases.
Who invested in Ambys Medicines
7 investors across 2 rounds
See all investors in Ambys Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ambys Medicines
Who invested in Ambys Medicines?
Ambys Medicines has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ambys Medicines raised?
Ambys Medicines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ambys Medicines last raise money?
Ambys Medicines's most recent round on record is a Series A, in Dec 2021.
What does Ambys Medicines do?
Ambys Medicines is a pharmaceuticals company.
Where is Ambys Medicines headquartered?
Ambys Medicines is headquartered in South San Francisco, US.
Which VCs invest in companies like Ambys Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Ambys Medicines's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Ambys Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.